UNICYCIVE THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Settlement, Percent
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Effective Income Tax Rate Reconciliation, Tax Settlement, Percent of 50.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements · last filed 2026-08-12
- UNICYCIVE THERAPEUTICS, INC. effective income tax rate reconciliation, tax settlement, percent for the quarter ending 2026-03-31 was 50.00%.
- UNICYCIVE THERAPEUTICS, INC. effective income tax rate reconciliation, tax settlement, percent for fiscal 2025 was 50.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, Percent 3 month | Effective Income Tax Rate Reconciliation, Tax Settlement, Percent 6 month | Effective Income Tax Rate Reconciliation, Tax Settlement, Percent 12 month |
|---|---|---|---|
| 2026-06-30 | 50.00% 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | 50.00% 10-Q · filed 2026-05-12 | ||
| 2025-12-31 | 50.00% 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |